Neural Regeneration Research ›› 2016, Vol. 11 ›› Issue (6): 886-889.doi: 10.4103/1673-5374.184451

Previous Articles     Next Articles

Oligodendrocyte ablation as a tool to study demyelinating diseases

Ahdeah Pajoohesh-Ganji, Robert H. Miller*   

  1. Department of Anatomy and Regenerative Biology, The George Washington University, School of Medicine and Health Sciences, Washington DC, USA
  • Online:2016-06-30 Published:2016-06-30
  • Contact: Robert H. Miller, Ph.D., rhm3@gwu.edu.
  • Supported by:

    This work has been supported in part by Genentech.

Abstract:

Multiple sclerosis (MS) is an autoimmune mediated neurodegenerative disease characterized by demyelination and oligodendrocyte (OL) loss in the central nervous system and accompanied by local inflammation and infiltration of peripheral immune cells. Although many risk factors and symptoms have been identified in MS, the pathology is complicated and the cause remains unknown. It is also unclear whether OL apoptosis precedes the inflammation or whether the local inflammation is the cause of OL death and demyelination. This review briefly discusses several models that have been developed to specifically ablate oligodendrocytes in an effort to separate the effects of demyelination from inflammation.

Key words: multiple sclerosis, oligodendrocyte, apoptosis, demyelination, optic neuritis